Eli Lilly and Company, Johnson & Johnson Development Corporation (JJDC), Pfizer Venture Investments
Founders
SV Health Investors
Company Description
TRexBio is a biotechnology company developing purpose-built therapeutics by leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology. Our Deep Biology platform maps human tissue Treg behavior to disease processes to identify and characterize novel targets for therapeutic intervention.
Market
Therapeutics
Location
South San Francisco,
California,
USA
Coinvestors
Agent Capital, Alexandria Venture Investments, Avego Bioscience Capital, Delos Capital, Eli Lilly and Company, Johnson & Johnson Development Corporation (JJDC), Pfizer Venture Investments, Polaris Partners, SV Health Investors